Platelet aggregating activity of plasma in patients with thrombotic thrombocytopenic purpura evaluated by a particle counting method using light scattering

International Journal of Hematology

Volumn 70, Issue 1, 1999, Pages 40-46

  Suehiro, Akira ^a   Yoshimoto, Hiroshi ^a   Higasa, Satoshi ^a   Kakishita, Eizo ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Particle counting method; Platelet activation; Small aggregate formation; Spontaneous platelet aggregation; Thrombotic thrombocytopenic purpura

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; DIPYRIDAMOLE;

ADOLESCENT; ADULT; ARTICLE; BLOOD; FEMALE; HUMAN; LIGHT; MALE; MIDDLE AGED; PARTICLE SIZE; PHYSIOLOGY; THROMBOCYTE AGGREGATION; THROMBOCYTOPENIC PURPURA;

ADOLESCENT; ADULT; ASPIRIN; DIPYRIDAMOLE; FEMALE; HUMANS; LIGHT; MALE; MIDDLE AGED; PARTICLE SIZE; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PURPURA, THROMBOCYTOPENIC;

EID: 0033163245     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Moake JL. Thrombotic microangiophathies: thrombotic thrombocytopenic purpurea and the hemolytic uremic syndrome. In: Loscalzo J, Schafer AI, editors. Thrombosis and Hemorrhage. Baltimore, Md: Williams & Wilkins; 1998:583-98.
2. Moake JL, McPherson PD. Abnormalities of von Willebrand factor multimers in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. Am J Med 1989;87:9N-15N.
3. Lian EC-Y, Harkness DR, Byrnes JJ, Wallach H, Nunez R. Presence of platelet aggregating factor in the plasma of patients with thrombotic thrombocytopenic purpura (TTP) and its inhibition by normal plasma. Blood 1979;53:333-8.
4. Remuzzi G, Misiani R, Mecca G, de Gaetano G, Donati MB. Thrombotic thrombocytopenic purpura - a deficiency of plasma factors regulating platelet-vessel wall interaction? [letter]. N Engl J Med 1978;299:311.
5. Kakishita E, Nakajima T, Suehiro A, et al. Studies of the pathogenesis and management of thrombotic thrombocytopenic purpura. Polish J Pharmacol 1996;48:179-84.
6. Ahn YS, Wenche JY, Kolodny L, et al. Activated platelet aggregates in thrombotic thrombocytopenic purpura: decreased with plasma infusions and normalization in remission. Br J Haematol 1996;95:408-15.
7. Born GVR. Quantitative investigations into the aggregation of blood platelets. J Physiol 1962;162:67-8.
8. Ozaki Y, Satoh K, Yatomi Y, Yamamoto T, Shirasawa Y. Detection of platelet aggregates with a particle counting method using light scattering. Anal Biochemistry 1994;218:284-94.
9. Qi R, Ozaki Y, Satoh K, et al. Intracellular levels of cyclic AMP and cyclic GMP differentially modify platelet aggregate size in human platelets activated with epinephrine or ADP. J Cardiovasc Pharmacol 1996;28:215-22.
10. Fukuda K, Ozaki Y, Satoh K, et al. Phosphorylation of myosin light chain in resting platelets from NIDDM patients is enhanced: correlation with spontaneous aggregation. Diabetes 1997;46:488-93.
11. Stein RS, Flexner JM. Idiopathic thrombocytopenic purpura during remission of thrombotic thrombocytopenic purpura. South Med J 1984;77:1599-601.
12. Chen S, Lian EC. Purification and some properties of a 59 Kda platelet aggregating protein from the plasma of an individual with thrombotic thrombocytopenic purpura. Blood 1988;72(suppl):318.
13. Siddiqui FA, Lian EC. Platelet agglutinating protein p37 from a thrombotic thrombocytopenic purpura plasma forms complexes with platelet membrane glycoprotein IV (CD36). Biochem Int 1992;27:485-96.
14. Moake JL, Chow TW. Increased von Willebrand factor (vWf) binding to platelets associated with impaired vWf breakdown in thrombotic thrombocytopenic purpura. J Clin Apheresis 1998;13:126-32.
15. Koyama T, Suehiro A, Kakishita E, et al. Efficacy of the high molecular weight fraction of plasma for the maintenance of pregnancy associated with thrombotic thrombocytopenic purpura. Am J Hematol 1990;35:179-83.
16. Koyama T, Kakishita E, Nagai K. Factors affecting the response to plasma therapy in thrombotic thrombocytopenic purpura. Jpn J Med 1989;28:16-21.
17. del Zoppo GL. Antiplatelet therapy in thrombotic thrombocytopenic purpura. Semin Hematol 1987;24:130-9.
18. Rosove MH, Ho WG, Goldfinger D. Ineffectiveness of aspirin and dipyridamole in the treatment of thrombotic thrombocytopenic purpura. Ann Intern Med 1982;96:27-33.
19. Mils DCB, Smith JB.The influence on platelet aggregation of drugs that affect the accumulation of adenosine 3′:5′-cyclic monophosphate in platelets. Biochem J 1971;121:185-96.
20. Roth GJ, Majerus PW. The mechanism of the effect of asipirin on human platelets. J Clin Invest 1975;56:624-32.